UK markets closed

Beam Therapeutics Inc. (BEAM)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
47.64+0.14 (+0.29%)
At close: 04:00PM EDT
48.00 +0.36 (+0.76%)
After hours: 07:14PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
76,916
51,844
24
18
0
Operating expenses
Research development
291,370
387,087
103,179
54,619
33,873
Selling general and administrative
76,855
57,222
29,605
20,553
11,868
Total operating expenses
368,225
444,309
132,784
75,172
45,741
Operating income or loss
-291,309
-392,465
-132,760
-75,154
-45,741
Interest expense
-
-
-
187
-
Total other income/expenses net
54,553
21,836
-63,400
-5,471
-71,289
Income before tax
-233,989
-370,638
-194,592
-78,326
-116,738
Income from continuing operations
-233,989
-370,638
-194,592
-78,326
-116,738
Net income
-233,989
-370,638
-194,592
-78,326
-115,257
Net income available to common shareholders
-233,989
-370,638
-195,869
-91,040
-115,257
Basic EPS
-
-5.77
-4.19
-2.01
-8.90
Diluted EPS
-
-5.77
-4.19
-2.01
-8.90
Basic average shares
-
64,228
46,733
45,325
12,953
Diluted average shares
-
64,228
46,733
45,325
12,953
EBITDA
-
-385,014
-128,025
-74,636
-45,091